The clinical significance of tumor cells in bone marrow or apheresis product and the efficacy of CD34+ selection and high-dose chemotherapy in patients with Stage III breast cancer. [electronic resource]
Producer: 20100107Description: 197-204 p. digitalISSN:- 1098-1101
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Blood Component Removal
- Bone Marrow Cells -- pathology
- Breast Neoplasms -- mortality
- Disease-Free Survival
- Female
- Follow-Up Studies
- Humans
- Middle Aged
- Neoplasm Metastasis
- Neoplasm Staging
- Neoplastic Cells, Circulating -- pathology
- Survival Rate
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.